Cost-effectiveness analyses of diabetes management: How to make them more clinically useful.

被引:0
|
作者
Safford, M
Pogach, L
Roman, S
Russell, L
机构
[1] Univ Med & Dent New Jersey, Newark, NJ 07103 USA
[2] VHA, E Orange, NJ USA
[3] CMS, Baltimore, MD USA
[4] Rutgers State Univ, New Brunswick, NJ 08903 USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:139 / 140
页数:2
相关论文
共 50 条
  • [1] THE EXTENSION OF THE COST-EFFECTIVENESS ACCEPTABILITY CURVE: HOW TO MAKE IT MORE INFORMATIVE?
    Kamae, I
    Araki, D.
    Kamae, M.
    VALUE IN HEALTH, 2011, 14 (03) : A152 - A152
  • [2] Hypertension guidelines: Criteria that might make them more clinically useful
    Campbell, N
    Feldman, R
    Drouin, D
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (08) : 698 - 699
  • [3] Hypertension guidelines: Criteria that might make them more clinically useful
    Alderman, MH
    Furberg, CD
    Kostis, JB
    Laragh, JH
    Psaty, BM
    Ruilope, LM
    Volpe, M
    Jackson, R
    AMERICAN JOURNAL OF HYPERTENSION, 2002, 15 (10) : 917 - 923
  • [4] Hypertension guidelines: Criteria that might make them more clinically useful - Reply
    Alderman, MH
    Volpe, M
    Furberg, CD
    Jackson, R
    Kostis, JB
    Laragh, JH
    Psaty, BM
    Ruilope, L
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (08) : 699 - 699
  • [5] Do rheumatology cost-effectiveness analyses make sense?
    Wolfe, F
    Michaud, K
    Pincus, T
    RHEUMATOLOGY, 2004, 43 (01) : 4 - 6
  • [6] Cost-effectiveness analyses of treatments for multiple sclerosis Are they clinically relevant?
    Smyth, Kathleen A.
    NEUROLOGY, 2011, 77 (04) : 317 - 318
  • [7] COST-EFFECTIVENESS ANALYSES OF INTERVENTIONS TO IMPROVE OSTEOPOROSIS MANAGEMENT
    Martin, J.
    Viprey, M.
    Castagne, B.
    Barral, M.
    Chapurlat, R.
    Julien, C.
    Serrier, H.
    Schott, A. -M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S528 - S529
  • [8] COST-BENEFIT AND COST-EFFECTIVENESS ANALYSES IN PEST-MANAGEMENT
    BICKNELL, K
    NEW ZEALAND JOURNAL OF ZOOLOGY, 1993, 20 (04) : 307 - 312
  • [9] How sensitive are cost-effectiveness analyses to choice of parametric distributions?
    Thompson, SG
    Nixon, RM
    MEDICAL DECISION MAKING, 2005, 25 (04) : 416 - 423
  • [10] How can we make measures of psychotic depression symptoms more clinically useful?
    Fava, M.
    ACTA PSYCHIATRICA SCANDINAVICA, 2014, 129 (03) : 161 - 162